SEC Filing Summary: National Health Investors, Inc. (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors, Inc. on May 4, 2026. The filing serves as a Regulation FD disclosure to disseminate an investor presentation and a press release titled "NHI Issues Investor Update" regarding the company's Q1 2026 business update.
Key Financial Metrics
The provided filing text does not contain specific financial data. It references an attached investor presentation (Exhibit 99.2) and press release (Exhibit 99.1) where details on revenue, profit, cash flow, margins, debt, and liquidity are presumably located, but these figures are not present in the cover page text.
Material Changes
No material changes to financial performance or operations are detailed in the text of this Form 8-K. The filing solely announces the release of the Q1 2026 business update materials.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in the attached exhibits (the investor presentation and press release) is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are enumerated in the cover page text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 financial results and operational highlights.
- Analyze Exhibit 99.2 (Investor Presentation) for detailed metrics on revenue, FFO, debt levels, and liquidity.
- Verify the company's forward-looking statements and guidance provided in the attached presentation.
- Confirm the date of the report (May 4, 2026) aligns with the fiscal period covered in the exhibits.